title: Measuring Attention in Rodents: Comparison of a Modified Signal Detection Task and the 5-Choice Serial Reaction Time Task.
abstract: Neuropsychiatric research has utilized cognitive testing in rodents to improve our understanding of cognitive deficits and for preclinical drug development. However, more sophisticated cognitive tasks have not been as widely exploited due to low throughput and the extensive training time required. We developed a modified signal detection task (SDT) based on the growing body of literature aimed at improving cognitive testing in rodents. This study directly compares performance on the modified SDT with a traditional test for measuring attention, the 5-choice serial reaction time task (5CSRTT). Adult male Sprague-Dawley rats were trained on either the 5CSRTT or the SDT. Briefly, the 5CSRTT required rodents to pay attention to a spatial array of five apertures and respond with a nose poke when an aperture was illuminated. The SDT required the rat to attend to a light panel and respond either left or right to indicate the presence of a signal. In addition, modifications were made to the reward delivery, timing, control of body positioning, and the self-initiation of trials. It was found that less training time was required for the SDT, with both sessions to criteria and daily session duration significantly reduced. Rats performed with a high level of accuracy (>87%) on both tasks, however omissions were far more frequent on the 5CSRTT. The signal duration was reduced on both tasks as a manipulation of task difficulty relevant to attention and a similar pattern of decreasing accuracy was observed on both tasks. These results demonstrate some of the advantages of the SDT over the traditional 5CSRTT as being higher throughput with reduced training time, fewer omission responses and their body position was controlled at stimulus onset. In addition, rats performing the SDT had comparable high levels of accuracy. These results highlight the differences and similarities between the 5CSRTT and a modified SDT as tools for assessing attention in preclinical animal models.
authors.affiliation: Queensland Brain Institute, The University of Queensland St. Lucia, QLD, Australia.
authors.forename: Karly M
authors.initials: KM
authors.lastname: Turner
authors.affiliation: Queensland Brain Institute, The University of Queensland St. Lucia, QLD, Australia.
authors.forename: James
authors.initials: J
authors.lastname: Peak
authors.affiliation: Queensland Brain Institute, The University of QueenslandSt. Lucia, QLD, Australia; Queensland Centre for Mental Health Research, The Park Centre for Mental HealthRichlands, QLD, Australia.
authors.forename: Thomas H J
authors.initials: TH
authors.lastname: Burne
keywords: 5CSRTT; animal models; attention; behavior; cognition; signal detection
references.citation: Biol Psychiatry. 2007 Sep 15;62(6):687-93
references.pmid: 17343834
references.citation: Front Behav Neurosci. 2013 Oct 23;7:154
references.pmid: 24167478
references.citation: Psychiatry Res. 1991 Apr;37(1):47-56
references.pmid: 1862161
references.citation: Psychopharmacology (Berl). 1995 Feb;117(3):340-57
references.pmid: 7770610
references.citation: Psychopharmacology (Berl). 2004 Jun;174(1):86-98
references.pmid: 15071717
references.citation: Neuropsychopharmacology. 2007 May;32(5):1122-32
references.pmid: 17047670
references.citation: Neuropsychopharmacology. 2007 Feb;32(2):483-92
references.pmid: 17035930
references.citation: Biol Psychiatry. 2008 Mar 1;63(5):490-7
references.pmid: 17631280
references.citation: Schizophr Bull. 2005 Oct;31(4):830-53
references.pmid: 16177277
references.citation: Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
references.pmid: 12373437
references.citation: Nat Protoc. 2008;3(5):759-67
references.pmid: 18451784
references.citation: Neuropharmacology. 2009 Mar;56(4):788-97
references.pmid: 19705572
references.citation: Arch Clin Neuropsychol. 2002 Apr;17(3):235-72
references.pmid: 14589726
references.citation: Neuropsychopharmacology. 2014 May;39(6):1519-26
references.pmid: 24385133
references.citation: Transl Psychiatry. 2013 Nov 12;3:e324
references.pmid: 24217494
references.citation: Schizophr Bull. 2007 Jan;33(1):49-68
references.pmid: 17101692
references.citation: Schizophr Bull. 2007 Sep;33(5):1131-7
references.pmid: 17630405
references.citation: Neurosci Biobehav Rev. 2013 Nov;37(9 Pt B):2099-110
references.pmid: 22683929
references.citation: Am J Psychiatry. 2008 Feb;165(2):203-13
references.pmid: 18172019
references.citation: Pharmacol Ther. 2009 May;122(2):150-202
references.pmid: 19269307
references.citation: Behav Brain Res. 2013 Apr 1;242:47-53
references.pmid: 23275047
references.citation: Schizophr Bull. 1994;20(1):31-46
references.pmid: 8197420
references.citation: Arch Gen Psychiatry. 2007 Jun;64(6):633-47
references.pmid: 17548746
references.citation: Schizophr Res. 2004 Dec 15;72(1):1-3
references.pmid: 15531401
references.citation: Biol Psychiatry. 2010 Jul 1;68(1):5-16
references.pmid: 20488434
references.citation: Curr Protoc Neurosci. 2003 May;Chapter 8:Unit 8.5E
references.pmid: 18428586
references.citation: J Neurosci. 2013 May 8;33(19):8321-35
references.pmid: 23658172
references.citation: Neuropsychology. 2008 Nov;22(6):787-99
references.pmid: 18999353
references.citation: Am J Med Genet. 2000 Spring;97(1):52-7
references.pmid: 10813804
references.citation: Psychopharmacology (Berl). 2012 Jan;219(2):253-70
references.pmid: 22089700
references.citation: Schizophr Bull. 2000;26(1):119-36
references.pmid: 10755673
references.citation: Behav Brain Res. 2011 Dec 1;225(2):574-83
references.pmid: 21888929
references.citation: Schizophr Res. 2013 Jun;147(1):75-80
references.pmid: 23570894
references.citation: Psychopharmacology (Berl). 2015 Nov;232(21-22):3853-72
references.pmid: 26202612
references.citation: Schizophr Bull. 2006 Jan;32(1):179-94
references.pmid: 16166612